NeuroD1/β2 contributes to cell-specific transcription of the proopiomelanocortin gene

Molecular and Cellular Biology

Volumn 17, Issue 11, 1997, Pages 6673-6682

  Poulin, Gino ^a   Turgeon, Benjamin ^a   Drouin, Jacques ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; BASIC HELIX LOOP HELIX PROTEINS; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BASIC HELIX-LOOP-HELIX PROTEINS; DNA BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; HOMEOBOX PROTEIN PITX1; HOMEODOMAIN PROTEIN; NERVE PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; PAIRED BOX TRANSCRIPTION FACTOR; PROOPIOMELANOCORTIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SPECIFICITY; DNA FLANKING REGION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOCHEMISTRY; PANCREAS CELL; PLASMID; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TATA BOX; BIOLOGICAL MODEL; BIOSYNTHESIS; CLASSIFICATION; CYTOLOGY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS; METABOLISM; PROTEIN BINDING; REGULATORY SEQUENCE; TISSUE DISTRIBUTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; DIMERIZATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELIX-LOOP-HELIX MOTIFS; HOMEODOMAIN PROTEINS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROTEIN BINDING; REGULATORY SEQUENCES, NUCLEIC ACID; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0030613544     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.11.6673     Document Type: Article

References (55)

1. Akerblom, I. E., E. C. Ridgway, and P. L. Mellon. 1990. An alpha-subunit-secreting cell line derived from a mouse thyrotrope tumor. Mol. Endocrinol. 4:589-596.
2. Andersen, B., and M. G. Rosenfeld. 1994. Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J. Biol. Chem. 269:29335-29338.
3. Aplan, P. D., K. Nakahara, S. H. Orkin, and I. R. Kirsch. 1992. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11:4073-4081.
4. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
5. Blackwell, T. K., and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110.
6. Boockfor, F. R., and L. K. Schwarz. 1988. Cultures of GH3 cells contain both single and dual hormone secretors. Endocrinology 122:762-764.
7. Chiaramello, A., K. Neuman, K. Palm, M. Metsis, and T. Neuman. 1995. Helix-loop-helix transcription factors mediate activation and repression of the p75LNGFR gene. Mol. Cell. Biol. 15:6036-6044.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thyocyanate-phenol-chloroform-extraction. Anal. Biochem. 162:156-159.
9. Cordle, S. R., E. Henderson, H. Masuoka, P. A. Weil, and R. Stein. 1991. Pancreatic β-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol. Cell. Biol. 11:1734-1738.
10. Davis, R. L., P.-F. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733-746.
11. Davis, R. L., and H. Weintraub. 1992. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 256:1027-1030.
12. Ellenberger, T., D. Fass, M. Arnaud, and S. C. Harrison. 1994. Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev. 8:970-980.
13. Fisher, F., and C. R. Goding. 1992. Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif. EMBO J. 11:4103-4109.
14. German, M. S., J. Wang, R. B. Chadwick, and W. J. Rutter. 1992. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev. 6:2165-2176.
15. Guillemot, F., L. C. Lo, J. E. Johnson, A. Auerbach, D. J. Anderson, and A. L. Joyner. 1993. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomie neurons. Cell 75:463-476.
16. Hasty, P., A. Bradley, J. Hsi Morris, D. G. Edmondson, J. M. Venuti, E. N. Olson, and W. H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-506.
17. Henthorn, P., R. McCarrick-Walmsley, and T. Kadesch. 1990. Sequence of the cDNA encoding ITF-1, a positive-acting transcription factor. Nucleic Acids Res. 18:677.
18. Ishibashi, M., S. L. Ang, K. Shiota, S. Nakanishi, R. Kageyama, and F. Guillemot. 1995. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev. 9:3136-3148.
19. Ishibashi, M., K. Moriyoshi, Y. Sasai, K. Shiota, S. Nakanishi, and R. Kageyama. 1994. Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J. 13:1799-1805.
20. Japon, M. A., M. Rubinstein, and M. J. Low. 1994. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J. Histochem. Cytochem. 42:1117-1125.
21. Jeannotte, L., M. A. Trifiro, R. K. Plante, M. Chamberland, and J. Drouin. 1987. Tissue-specific activity of the pro-opioomelanocortin gene promoter. Mol. Cell. Biol. 7:4058-4064.
22. Kageyama, R., Y. Sasai, C. Akazawa, M. Ishibashi, K. Takebayashi, C. Shimizu, K. Tomita, and S. Nakanishi. 1995. Regulation of mammalian neural development by helix-loop-helix transcription factors. Crit. Rev. Neurobiol. 9:177-188.
23. Karlsson, O., T. Edlund, J. B. Moss, W. J. Rutter, and M. D. Walker. 1987. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc. Natl. Acad. Sci. USA 84:8819-8823.
24. Kawamura, K., and S. Kikuyama. 1992. Evidence that hypophysis and hypothalamus constitute a single entity from the primary stage of histogenesis. Development 115:1-9.
25. Kawamura, K., and S. Kikuyama. 1995. Induction from posterior hypothalamus is essential for the development of the pituitary proopiomelacortin (POMC) cells of the toad (Bufo japonicus). Cell Tissue Res. 279:233-239.
26. Kikuyama, S., H. Inaco, B. G. Jenks, and K. Kawamura. 1993. Development of the ectopically transplanted primordium of epithelial hypophysis (anterior neural ridge) in Bufo japonicus embryos. J. Exp. Zool. 266:216-220.
27. Lamonerie, T., J. J. Tremblay, C. Lanctôt, M. Therrien, Y. Gauthier, and J. Drouin. 1996. PTX1, a bicoid-related homeobox transcription factor involved in transcription of pro-opiomelanocortin (POMC) gene. Genes Dev. 10: 1284-1295.
28. Lanctôt, C., B. Lamolet, and J. Drouin. 1997. The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm. Development 124:2817.
29. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
30. Lee, J. E., S. M. Hollenberg, L. Snider, D. L. Turner, N. Lipnick, and H. Weintraub. 1995. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268:836-844.
31. Ma, P. C., M. A. Rould, H. Weintraub, and C. O. Pabo. 1994. Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell 77:451-459.
32. Ma, Q. F., C. Kintner, and D. J. Anderson. 1996. Identification of neurogenin, a vertebrate neuronal determination gene. Cell 87:43-52.
33. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
34. McCormick, M. B., R. M. Tamimi, L. Snider, A. Asakura, D. Bergstrom, and S. J. Tapscott. 1996. NeuroD2 and NeuroD3: distinct expression patterns and transcriptional activation potentials within the NeuroD gene family. Mol. Cell. Biol. 16:5792-5800.
35. McDonald, S., G. Poulin, T. Lamonerie, M. Therrien, and J. Drouin. HLH transcription factors act at multiple sites to control POMC gene expression. Submitted for publication.
36. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by mef2 and myogenic bhlh proteins. Cell 83:1125-1136.
37. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
38. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
39. Mutoh, H., B. P. Fung, F. J. Naya, M. J. Tsai, J. Nishitani, and A. B. Leiter. 1997. The basic helix-loop-helix transcription factor beta2/neurod is expressed in mammalian enteroendocrine cells and activates secretin gene expression. Proc. Natl. Acad. Sci. USA 94:3560-3564.
40. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535.
41. Naya, F. J., C. M. M. Stellrecht, and M. J. Tsai. 1995. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 9:1009-1019.
42. Nelson, C., L. P. Shen, A. Meister, E. Fodor, and W. J. Rutter. 1990. Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev. 4:1035-1043.
43. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6:454-456.
44. Olson, E. N., and W. H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
45. Peers, B., J. Leonard, S. Sharma, G. Teitelman, and M. R. Montminy. 1994. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol. Endocrinol. 8:1798-1806.
46. Rudnicki, M. A., P. N. Schnegelsberg, R. H. Stead, T. Braun, H. H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
47. Schwind, J. 1928. The development of the hypophysis cerebri of the albino rat. Am. J. Anat. 41:295-319.
48. Shivdasani, R. A., E. L. Mayer, and S. H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432-434.
49. Sun, X.-H., and D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64:459-470.
50. Therrien, M., and J. Drouin. 1991. Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Mol. Cell. Biol. 11:3492-3503.
51. Therrien, M., and J. Drouin. 1993. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol. Cell. Biol. 13:2342-2353.
52. Voss, J. W., and M. G. Rosenfeld. 1992. Anterior pituitary development: short tales from dwarf mice. Cell 70:527-530.
53. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
54. Windle, J. J., R. I. Weiner, and P. L. Mellon. 1990. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol. Endocrinol. 4:597-603.
55. Zhang, W., R. R. Behringer, and E. N. Olson. 1995. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev. 9:1388-1399.